Predict your next investment

Corporation
HEALTHCARE | Drug Development
wafergen.com

See what CB Insights has to offer

Founded Year

2002

Stage

Acq - P2P | Acquired

About WaferGen Bio-systems

WaferGen markets SmartChip TE (Target Enrichment for Next-Generation Sequencing (NGS)) and SmartChip MyDesign (high-throughput quantitative PCR) products. SmartChip TE addresses CLIA-certified and clinical research laboratories' significant unmet needs in sequencing-based testing by providing uniform coverage of targeted genes, yielding better test specificity and sensitivity. The superior performance of this new product is based on WaferGen's proprietary technology that relies on massively parallel singleplex PCR reactions, where amplification is cleaner and better controlled, thereby providing more accurate diagnostic test results in the downstream sequencing step. On the qPCR side, the SmartChip MyDesign System has a powerful value proposition of content design flexibility, cost-effectiveness, and no need for pre-amplification.

WaferGen Bio-systems Headquarter Location

Bayside Technology Center 46531 Fremont Boulevard

Fremont, California, 94538,

United States

510-651-4450

Latest WaferGen Bio-systems News

Global Single Cell Analysis Market Overview, Trends and Forecast 2017 – 2025 | Industry Research Report Key players – WaferGen Bio-systems, Inc., Thermo Fisher Scientific, Inc., Dickinson and Company

Oct 6, 2018

Single Cell Analysis Market: Introduction Single cell analysis is majorly used in cellular biology for the study of transcriptomics, genomics, metabolomics, and proteomics at a single cellular level. Due to the major differences observed in between eukaryotic and prokaryotic cells, the single cell analysis will make it possible to discover various mechanisms which are not observed in a study of bulk cells population. Request for a sample copy of this report @  https://www.insightsandreports.com/request-sample/202 Market Dynamics Increasing single cell analysis applications in genomics, proteomics, epigenetic studies, and transcriptomics, will significantly propel the single cell analysis market growth. Moreover, the demand of single cell analysis for clinical trials is increasing at a significant rate. At present, nearly 1,300 clinical trials are in progress, and the single cell analysis acts as an effective diagnosis tool of various cancer types and infections such as hepatitis, Influenza, and HIV through immunology. According to a study by Cancer Research UK, more than 14.2 million worldwide cases were identified in 2012, out of which 8.2 million deaths were registered. Increasing incidences of cancer cases will give a significant boost to the growth of single cell analysis market. Likewise, potential players operating in the pharmaceutical industry are investing hugely in the research and development (R&D) activities to assess various single cell analysis applications in stem cell transplant procedures to improve their success rates. Moreover, the introduction of several advanced devices which can enable easy proteomics and transcriptomic procedures will further trigger the adoption of single cell analysis operations. The single cell analysis market is expected to restrain due to the high costs instruments used for this analysis procedures. The demand for analytical tools is increasing, which is significantly enhancing new technical advancements, which is leading to the development of high-end machinery. Due to the increasing need for accuracy, high sensitivity, and efficacy, the manufacturers in this sector are investing hugely in their product development activities, which will open some significant growth opportunities for the single cell analysis market. By Product Type The global single cell analysis market has been segmented by product into consumables and instruments. Consumables for single cell analysis market is expected to lead with prime share over the forecast period. This is majorly due to the increasing frequent requirement of these products compared to instruments. The investment on the instruments is considered as a one-time investment. Some of the consumables used in the single cell analysis include reagents & kits, micro-consumables, etc. Among the consumables, the demand for reagents is expected to grow at a prime growth rate than micro-consumables, owing to their increasing consumption requirement in the cellular analysis operations. By Technique Type Single cell analysis through flow cytometry technique is expected to hold the largest market share of the overall market over the forecast period, owing to increasing usage in cellular analysis operations. This is majorly attributed by the favorable properties offered by this technique such as higher accuracy, efficiency, and sensitivity, when compared to other techniques. By Application Single cell analysis market for cancer application is expected to have the highest market share, primarily owing to its increasing use in the research & development on various types of cancers. This technique is majorly used in cancer genomics, majorly to identify the cancer-specific gene signatures. By Region North America single cell analysis market is projected to have the prime market share, majorly owing to increasing research & development activities, coupled with rising cancer cases and geriatric population. By the end of 2016, the cancer survivors in U.S. reached 15.5 million, and this is projected to reach 20.3 million by the end of 2026, according to the National Cancer Institute. Moreover, R&D investment in the biopharmaceutical industry reached US$ 90.0 billion in 2016, according to a report by PhRMA. This will give a significant boost to the growth of North America single cell analysis market over the projected period. Asia Pacific single cell analysis market is predicted to have a second highest market share in the global market, primarily owing to increasing development activities in the healthcare sector, coupled with rising geriatric population, and cancer incidences. According to a report “Call for Action: Expanding cancer care for women in India, cancer among women in India was estimated over 0.7 million, while several cases were undetected or unreported. For more information about this report @  https://www.insightsandreports.com/industry-reports/single-cell-analysis-market Key players Some of the potential players in the global single cell analysis market include WaferGen Bio-systems, Inc., Thermo Fisher Scientific, Inc., Dickinson and Company, Becton, Eppendorf AG, Fluidigm Corporation, NuGEN Technologies, Inc., QIAGEN N.V., Bio-Rad Laboratories, Inc., 10x Genomics, and Illumina, Inc. among several others. According to the National Institute of Health, there were some rapid technology developments in the past few years, which permitted the development of detailed single cell genome and transcriptome analysis. Many prominent players operating in this market are focusing more on the development of new and innovative technologies, which will help the market growth on a rapid scale. For instance, in August 2018, Cytobank aimed to improve cytometrt informatics, and they are planning to start with immunotherapy. About Us: Insights and Reports is a research and consulting group assisting the clients with 360-degree insights with real time qualitative and quantitative information. The Insights and Reports team is valued for continuous client-oriented services. Our data scientists monitor the markets pertaining to their expertise on a daily basis with the help of 150+ analysts to back them with accurate market studies. Contact Us:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing WaferGen Bio-systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

WaferGen Bio-systems is included in 1 Expert Collection, including Omics.

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

WaferGen Bio-systems Patents

WaferGen Bio-systems has filed 17 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Molecular biology techniques
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/20/2016

5/5/2020

Molecular biology, Cell biology, Biotechnology, Transcription factors, Clusters of differentiation

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/20/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

5/5/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Cell biology, Biotechnology, Transcription factors, Clusters of differentiation

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.